Article
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection
29 Oct 2022
Abstract excerpt
Communicable respiratory viral infections pose both epidemic and pandemic threats and broad-spectrum antiviral strategies could improve preparedness for these events. To discover host antiviral restriction factors that may act as suitable targets for the development of host-directed antiviral therapies, we here conduct a whole-genome CRISPR activation screen with influenza B virus (IBV). A top hit from our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
